51202413 Secukinumab

Definition

UNSPSC 51202413

This classification denotes an immunosuppressant that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DLG4EML025, generally known as secukinumab. European Medicines Agency schedules secukinumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33242. The term SECUKINUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 1, 2010 List 63). Most nations, for tariff and trade purposes, schedule SECUKINUMAB under HS 29349990 and SITC 51579. SMILES: none.

Same parent

Under 51202400 · 21

51202401 Adalimumab Commodity 51202402 Basiliximab Commodity 51202403 Belimumab Commodity 51202404 Canakinumab Commodity 51202405 Certolizumab Commodity 51202406 Certolizumab pegol Commodity 51202407 Dacliximab or daclizumab Commodity 51202408 Eculizumab Commodity 51202409 Infliximab Commodity 51202410 Muromonab cd3 Commodity 51202411 Natalizumab Commodity 51202412 Omalizumab Commodity 51202413 Secukinumab You are here 51202414 Ustekinumab Commodity 51202415 Ramucirumab Commodity 51202416 Daratumumab Commodity 51202417 Golimumab Commodity 51202418 Siltuximab Commodity 51202419 Dinutuximab Commodity 51202420 Polygala fluid extract Commodity 51202421 Thymalfasin Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51200000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class